| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446746 | European Journal of Cancer | 2012 | 9 Pages |
Abstract
We conclude that most neuroblastoma cell lines are sensitive to YM155 in the low nM range and that resistant cells can be sensitised by ABCB1 inhibitors. Therefore YM155 is a promising novel compound for treatment of neuroblastoma with low ABCB1 expression.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Fieke Lamers, Linda Schild, Jan Koster, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar,